ATE367807T1 - Thioharnstoff-enthaltendes arzneimitel zur verwendung als depigmentierungsmittel oder als antimutagen und antikarzinogen - Google Patents

Thioharnstoff-enthaltendes arzneimitel zur verwendung als depigmentierungsmittel oder als antimutagen und antikarzinogen

Info

Publication number
ATE367807T1
ATE367807T1 AT03776954T AT03776954T ATE367807T1 AT E367807 T1 ATE367807 T1 AT E367807T1 AT 03776954 T AT03776954 T AT 03776954T AT 03776954 T AT03776954 T AT 03776954T AT E367807 T1 ATE367807 T1 AT E367807T1
Authority
AT
Austria
Prior art keywords
anticarcinogene
depigmentant
antimutagen
medicinal product
containing medicinal
Prior art date
Application number
AT03776954T
Other languages
English (en)
Inventor
Daniel Jean
Cherif Rabhi
Original Assignee
Lmd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lmd filed Critical Lmd
Application granted granted Critical
Publication of ATE367807T1 publication Critical patent/ATE367807T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03776954T 2002-10-11 2003-10-03 Thioharnstoff-enthaltendes arzneimitel zur verwendung als depigmentierungsmittel oder als antimutagen und antikarzinogen ATE367807T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0212697A FR2845599B1 (fr) 2002-10-11 2002-10-11 Medicament comprenant une thiouree pour son utilisation en tant que depigmentant

Publications (1)

Publication Number Publication Date
ATE367807T1 true ATE367807T1 (de) 2007-08-15

Family

ID=32039668

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03776954T ATE367807T1 (de) 2002-10-11 2003-10-03 Thioharnstoff-enthaltendes arzneimitel zur verwendung als depigmentierungsmittel oder als antimutagen und antikarzinogen

Country Status (12)

Country Link
US (1) US20060135618A1 (de)
EP (1) EP1553933B1 (de)
JP (1) JP2006509733A (de)
KR (1) KR20050094806A (de)
AT (1) ATE367807T1 (de)
AU (1) AU2003286213A1 (de)
CA (1) CA2501742A1 (de)
DE (1) DE60315176D1 (de)
FR (1) FR2845599B1 (de)
MX (1) MXPA05003891A (de)
NO (1) NO20052176L (de)
WO (1) WO2004032912A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881654B1 (fr) * 2005-02-07 2009-05-29 Lmd Compositions medicinales contenant une alkylsulfone pour le traitement du cancer en association a des agents chimiotherapeutiques ou a des rayonnements ionisants ou non ionisants
FR2890070A1 (fr) * 2005-08-31 2007-03-02 Galderma Res & Dev Nouveaux inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
WO2007039821A2 (en) * 2005-08-31 2007-04-12 Galderma Research & Development Novel inhibitors of tyrosinase, their method of preparation and their use in human medicine and in cosmetics
WO2008015315A1 (fr) * 2006-08-03 2008-02-07 Lmd Compositions medicinales contenant une thiouree pour le traitement du cancer en association avec des agents chimiotherapeutiques ou des rayonnements ionisants ou non ionisants
EA201270016A1 (ru) * 2009-06-09 2012-06-29 Марди Медисинс Лтд. Галогенированные алифатические карбоновые кислоты, их олигомеры и/или полимеры и их применение для девитализации внешних и внутренних новообразований
BE1019431A3 (fr) * 2010-07-23 2012-07-03 Auriga Internat Procede de synthese d'isothiocyanates et leurs derives et utilisations de ceux-ci.
BE1019432A3 (fr) * 2010-07-23 2012-07-03 Auriga Internat Utilisation d'isothiocyanates et derives pour le traitement et/ou la prevention des lucites.
AU2013269340B9 (en) 2012-06-01 2017-08-17 Pharmagra Labs, Inc. Method of synthesising sulforaphane
TWI508950B (zh) * 2014-08-29 2015-11-21 Univ Hungkuang 3-methyl-2-sulfanyl-2,3-dihydro-1H-imidazole-1-carboxylic acid Tertiary butyl ester and its preparation method and use
WO2018046243A1 (en) 2016-09-06 2018-03-15 Unilever N.V. Compounds for reducing cellular melanin content
KR102201385B1 (ko) * 2018-10-11 2021-01-11 주식회사 그라젬 피부 미백용 조성물 및 이를 이용한 미백용 화장품

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411986A (en) * 1993-03-12 1995-05-02 The Johns Hopkins University Chemoprotective isothiocyanates
WO2001064206A2 (en) * 2000-02-29 2001-09-07 Integriderm, Inc. Inhibitors of melanocyte tyrosinase as topical skin lighteners
FR2820036B1 (fr) * 2001-01-26 2005-12-09 L M D Utilisation d'un isothiocyanate, d'un thiocyanate ou de leur melange en tant que depigmentant

Also Published As

Publication number Publication date
MXPA05003891A (es) 2005-08-03
US20060135618A1 (en) 2006-06-22
JP2006509733A (ja) 2006-03-23
AU2003286213A1 (en) 2004-05-04
DE60315176D1 (de) 2007-09-06
WO2004032912A1 (fr) 2004-04-22
NO20052176L (no) 2005-05-03
EP1553933B1 (de) 2007-07-25
FR2845599A1 (fr) 2004-04-16
KR20050094806A (ko) 2005-09-28
FR2845599B1 (fr) 2005-01-07
CA2501742A1 (fr) 2004-04-22
EP1553933A1 (de) 2005-07-20

Similar Documents

Publication Publication Date Title
ATE367807T1 (de) Thioharnstoff-enthaltendes arzneimitel zur verwendung als depigmentierungsmittel oder als antimutagen und antikarzinogen
NO20051209L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk anvendelse derav samt intermediater for samme
AU2804400A (en) Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
HUP0400206A2 (hu) Metalloproteináz inhibitor hatású imidazolidin-dion-származékok, ezek alkalmazása gyógyszerkészítmények előállítására és ezeket tartalmazó gyógyszerkészítmények
HUP0302451A2 (hu) (Tio)karbamoil-ciklohexán származékok, eljárás előállításukra és ezeket hatóanyagként tartalmazó gyógyszerkészítmények
DE60330407D1 (de) Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung
BR0311952A (pt) Novos compostos úteis para o tratamento de obesidade, diabetes tipo ii e distúrbios do snc
BRPI0407283A (pt) Composto, composição farmacêutica, e, agente ativador de glucoquinase, agentes terapêuticos e/ou agentes preventivos para diabetes melito e obesidade
BR0013667A (pt) Derivados de glucopiranosiloxipirazol, composições medicinais contendo os mesmos derivados e seus intermediários na produção dos mesmos
UY23364A1 (es) Nuevas sulfonilureas
ATE268752T1 (de) Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung
ATE548032T1 (de) Verwendung von chlorguanabenzderivaten zur behandlung von mit polyglutaminexpansion assoziierten erkrankungen
TR200103349T2 (tr) Purin türevleri, hazırlama usulü ve bunları içeren ispençiyari bileşimleri.
BRPI0415020A (pt) dissulfeto, sulfeto, sulfóxido e derivados de sulfona de açúcares cìclicos e usos dos mesmos
BR0209650A (pt) Análogos de adenosina para o tratamento da sìndrome de resistência à insulina e da diabetes
DE60137442D1 (de) 5-amidino-2-hydroxybenzolsulfonamidderivate, pharmazeutischen zusammensetzungen, die diese verbindungen enthalten, und zwischenprodukte zu deren herstellung
ATE487685T1 (de) (-)-stereoisomer von 2,6-di-sec-butylphenol und analoga davon
SE8300855L (sv) Nya piperazin- och homopiperazinderivat, forfaranden for framstellning derav och farmaceutiska kompositioner innehallande dem
BR9809643A (pt) Compostos heterocìclicos, seu processo de preparo e as composições farmacêuticas que os contêm
DE602004019778D1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
ATE425174T1 (de) Colchicosidanaloge
MXPA03006731A (es) Uso de un isotiocianato, de un tiocianato, o una mezcla de los mismos, como agente de despigmentacion.
HUP0105111A1 (hu) 2,5-Helyettesített benzolszulfonilkarbamid- és tiokarbamidszármazékok, eljárás előállításukra, alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
MA27649A1 (fr) Derives d&#39;acylphenyluree substitues par carbonylamino, methode de production et d&#39;utilisation de ceux-ci.
ATE118346T1 (de) Verwendung von bis(4-hydroxyphenylthio)methan- derivaten zur behandlung von diabetes mellitus.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties